The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Adherex Technologies

  • AHX.WT
  • TSX
  • Consumer Products
  • Latest 0.025
  • Currency C$
  • Change
  • Percent Change
  • Volume --
  • Thu May 16, 2013 11:14 AM EDT TSX data delayed 15 minutes.
  • Open --
  • Previous Close 0.025
  • High --
  • Low --
  • Bidx5 0.02
  • Askx391 0.025
  • 52-week High 12/06 0.04
  • 52-week Low 10/10 0.005
  • Beta 1.127
  • Market Cap 26.67M
  • EPS 0.20
  • P/E 0.13
  • Forward P/E --
  • PEG --
  • Annual Dividend --
  • Yield --

News

Financials & Calendars

Income Statement

  • Sales n/a
  • Earnings n/a
  • Return on Equity n/a

Cash Flow

  • Cash Flow $-2,964,000
  • Cash $1,896,000
  • Current Ratio 0.18

12 months ended Mar 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $1,938,000
  • Liabilities $11,003,000
  • Liabilities-to-Equity Ratio n/a

Price Ratios

  • Price to Sales n/a
  • Price to Book n/a
  • Price to Cash Flow -0.21

Event Calendar

Event Last   Next  
Earnings May 15 n/a Aug 15 n/a
Surprises n/a n/a n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended May 23, 2013.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

ADHEREX TECHNOLOGIES INC. is a biopharmaceutical company focused on the development of eniluracil and 5 fluorouaricil currently enrolling a Phase II study.

Related Securities
Symbol Type Latest % Chg

Officers

  • Rosty Raykov C.E.O.
  • Robert Andrade C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: n/a
  • Incorporation: Canada,
    n/a
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

PO Box 13628
Research Triangle, NC

Phone: (919)-636-4530
Fax: (919)-8900490

info@adherex.com
www.adherex.com

Ideas & Discussion

Live Discussion of AHX.WT on StockTwits